Bausch + Lomb has announced the appointment of Calvin W.
Roberts, M.D. to the newly created position of Chief Medical Officer (CMO). Dr.
Roberts will serve as a member of the Executive Leadership Team and coordinate
the company's global D&R efforts across the Vision Care, Pharmaceuticals
and Surgical business units for greater leverage and outcomes.
Dr. Roberts brings a unique combination of academic,
clinical and product development experience to the new Bausch + Lomb CMO role.
A specialist in cataract and refractive surgery, Dr. Roberts is credited with
developing and producing over-the-counter products for vision care,
prescription ocular therapeutics and innovative treatment regimens. Dr. Roberts
is considered to be the "father" of ophthalmic non-steroidals; he has
published 50 peer-reviewed articles.
"We are extremely pleased with the addition of Dr.
Calvin Roberts to the Bausch + Lomb leadership team in this critical new role
as chief medical officer," said Brent Saunders, chief executive officer of
Bausch + Lomb. "As a renowned expert in ophthalmology and the development
of eye health products, Cal
is uniquely qualified to help us further strengthen product innovation,
benefiting our customers and their patients around the world."
Dr. Roberts is a member of the board of directors at Alimera
Sciences, a biopharmaceutical company he co-founded in 2003. Dr. Roberts is a
clinical professor of ophthalmology at Weill Medical College of Cornell
University. Dr. Roberts holds patents on the wide-field specular microscope,
used for corneal endothelial studies, and is the developer of instruments for
cataract surgery. As a consultant to ophthalmic pharmaceutical companies,
including Allergan Pharmaceuticals, Johnson & Johnson and Novartis, Dr.
Roberts has helped lead the development and marketing efforts for several new
therapeutics.
A graduate of Princeton
University and the College of Physicians
and Surgeons of Columbia University, Dr. Roberts completed his internship and
ophthalmology residency at Columbia Presbyterian Hospital
in New York.
Dr. Roberts also completed cornea fellowships at Massachusetts Eye and Ear
Infirmary and the Schepens Eye Research Institute in Boston.
"I look forward to bringing the perspective of clinical
optometrists and ophthalmologists to the development of new, innovative
products to benefit our patients," said Dr. Calvin Roberts. "Bausch +
Lomb has a history of great science and great scientists, and working together
we can best serve the needs of our customers and patients."